Journals / The Anatolian Journal of Cardiology / 2022 / Cilt: 26 - Sayı: 6

Molecular Approach of Hereditary Arrhythmias, Long QT Syndrome, and Arrhythmogenic Right Ventricular Cardiomyopathy

Pages
460–465
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is necessary to study with a broad perspective to elucidate the underlying molecular etiology in patients with hereditary cardiac arrhythmias.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Hereditary cardiac arrhythmias result from mutations in various genes encoding ion channels.
📊
Key Findings & Data:Methods: In this study, we performed clinical exome sequencing or gene panel including cardiac arrhythmia and cardiomyopathy-associated genes by next-generation sequencing in 13 unrelated patients.
💡
Conclusion & Impact:It is necessary to study with a broad perspective to elucidate the underlying molecular etiology in patients with hereditary cardiac arrhythmias.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: Hereditary cardiac arrhythmias result from mutations in various genes encoding ion channels. One major channelopathy is long QT syndrome, which has excellent genetic and clinical heterogeneity. Arrhythmogenic right ventricular cardiomyopathy, another hereditary arrhythmia type, also shows high genetic heterogeneity and variable expressivity. Next-generation sequencing is an effective tool to reveal the disease’s underlying genetic etiology. Methods: In this study, we performed clinical exome sequencing or gene panel including cardiac arrhythmia and cardiomyopathy-associated genes by next-generation sequencing in 13 unrelated patients. Results: Five pathogenic or likely pathogenic mutations, including three novel mutations, were found in the total cases. Conclusion: This research shows a strong genetic heterogeneity in the disease. In addition, the study revealed that patients with QT interval prolongation on electrocardiogram might also have mutations in genes that are not associated with long QT syndrome, such as MYLK2 and DSG2. Therefore, our data helped expand the molecular scope of long QT syndrome. It is necessary to study with a broad perspective to elucidate the underlying molecular etiology in patients with hereditary cardiac arrhythmias.

🔖

Cite This Article

BAHSİ, T., SAAT, H., ÖZGÜR, S., ERDEM, H. B., ŞAHİN, İ., TOKGÖZ, S. T. (2022). Molecular Approach of Hereditary Arrhythmias, Long QT Syndrome, and Arrhythmogenic Right Ventricular Cardiomyopathy. The Anatolian Journal of Cardiology, Cilt: 26 - Sayı: 6, 460–465. https://ajindex.com/articles/597216

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Kline J, Costantini O. Inherited cardiac arrhythmias and Channelopathies. Med Clin North Am. 2019
  2. 103(5):809-820. [CrossRef] 2. Nakano Y, Shimizu W. Genetics of long-QT syndrome. J Hum Genet. 2016
  3. 61(1):51-55. [CrossRef] 3. Mizusawa Y, Horie M, Wilde AA. Genetic and clinical advances in congenital long QT syndrome. Circ J. 2014
  4. 78(12):2827-2833. [CrossRef] 4. Wallace E, Howard L, Liu M, et al. Long QT syndrome: genetics and future Perspective. Pediatr Cardiol. 2019
  5. 40(7):1419-1430. [CrossRef] 5. Cadrin-Tourigny J, Bosman LP, Wang W, et al. Sudden cardiac death prediction in arrhythmogenic right ventricular cardiomyopathy: a multinational collaboration. Circ Arrhythm Electrophysiol. 2021
  6. 14(1):e008509. [CrossRef] 6. Vimalanathan AK, Ehler E, Gehmlich K. Genetics of and pathogenic mechanisms in arrhythmogenic right ventricular cardiomyopathy. Biophys Rev. 2018
  7. 10(4):973-982. [CrossRef] 7. Louis C, Calamaro E, Vinocur JM. Hereditary arrhythmias and cardiomyopathies: decision-making about genetic testing. Curr Opin Cardiol. 2018
  8. 33(1):78-86. [CrossRef] 8. Campuzano O, Sarquella-Brugada G, Mademont-Soler I, et al. Identification of genetic alterations, as causative genetic defects in long QT syndrome, using next generation sequencing technology. PLoS One. 2014
  9. 9(12):e114894. [CrossRef] 9. Davis JS, Hassanzadeh S, Winitsky S, et al. The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation. Cell. 2001
  10. 107(5):631- 641. [CrossRef] 10. Wang J, Guo RQ, Guo JY, et al. Investigation of myocardial dysfunction using three-dimensional speckle tracking echocardiography in a genetic positive hypertrophic cardiomyopathy Chinese family. Cardiol Young. 2018
  11. 28(9):1106-1114. [CrossRef] 11. Qin X, Li P, Qu HQ, et al. FLNC and MYLK2 gene mutations in a Chinese family with different phenotypes of cardiomyopathy. Int Heart J. 2021
  12. 62(1):127-134. [CrossRef] 12. Haugaa KH, Leren IS. Prevalence, clinical presentation, and management of channelopathies and cardiomyopathies, long QT syndrome, Brugada syndrome, arrhythmogenic cardiomyopathy and hypertrophic cardiomyopathy. Curr Cardiovasc Risk Rep. 2019
  13. 13(7):1-7. [CrossRef] 13. Oktem A, Doolan BJ, Akay BN, et al. Autosomal recessive mutations in plakoglobin and risk of cardiac abnormalities. Clin Exp Dermatol. 2020
  14. 45(5):654-657. [CrossRef] 14. Liu L, Chen C, Li Y, Yu R. Whole-exome sequencing identified a de novo mutation of junction plakoglobin (p.R577C) in